We aimed to examine the duration of KPC KP carriage following hospital discharge and to study the risk factors for persistent carriage. A cohort of 125 KPC KP known carriers was followed between 3 to 5 months after discharge from an acute-care hospital. Rectal swabs and data were collected at enrollment and at each visit. KPC KP was detected by culture and direct blaKPC-PCR. Resolution of carriage was defined as a negative KPC KP tests in at-least 2 consecutive samples. Analyses were separated for recent (<4 months) (REC, 75 patients) and remote (>4 months) (REM, 50 patients) acquisition groups. The mean age of patients was 67.5 years and 49.6% were males. Forty-six (61%) patients in the REC and 14 (28%) in the REM group, were persistent carriers (p<0.001). Significant risk factors for persistent carriage identified in both the REC and REM groups were the presence of any catheter (p<0.05). Unique risk factors groups included long-term care facility (LTCF) residence (p<0.01) and a low functional status (p<0.05) in the REC group and high Charlson's score in the REM grou (p<0.05). Out of 100 patients who had at least one negative sample, only 65 remained negative on subsequent cultures. In conclusion, persistent carriage of KPC KP is associated with catheter use and a low functional status; it is more common in patients with recent acquisition, and is related to LTCF stay. A single negative KPC KP test is insufficient to exclude persistent carriage. 
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Abstract
The natural history of KPC-producing Klebsiella pneumoniae (KPC KP) carriage is unknown. We aimed to examine the duration of KPC KP carriage following hospital discharge and to study the risk factors for persistent carriage.
A cohort of 125 KPC KP carriers was followed monthly between 3 to 6 months after discharge from an acute-care hospital. Rectal swabs and data were collected at baseline and at each visit. KPC KP was detected by culture and direct bla KPC PCR.
Acquisition time was regarded as the earliest date of KPC KP isolation. Resolution of carriage was defined as a negative KPC KP tests in at-least 2 consecutive samples.
Analyses were separated for recent (<4 months) (REC, 75 patients) and remote (>4 months) (REM, 50 patients) acquisition groups. Risk factors for persistent carriage were examined by survival analyses for the REC group and by prevalence methods for the REM group.
The mean age of patients was 67.5 years and 49.6% were males. Forty-six (61%) patients in the REC and 14 (28%) in the REM group, were persistent carriers (p<0.001). Significant risk factors for persistent carriage identified in both the REC and REM groups were the presence of any catheter (p<0.05). Unique risk factors groups included long-term care facility (LTCF) residence (p<0.01) and a low functional status as measured by the Barthel's index (p<0.05) in the REC group and high Charlson's score in the REM group (p<0.05). Out of the entire 100 patients who had at least one negative sample, only 65 remained negative on subsequent cultures.
In conclusion, persistent carriage of KPC KP is associated with catheter use and a low functional status; it is more common in patients with recent acquisition, and is related to LTCF stay. A single negative KPC KP test is insufficient to exclude persistent carriage. [1] [2] [3] . Since then, KPC-producing K. pneumoniae (KPC KP) have spread and become endemic in several countries in Europe, the Middle East, Asia and South America [4, 5] . This epidemic is caused by a predominantly monoclonal dissemination of the Sequence-Type (ST)-258 and its Clonal Complex (CC) [6] [7] [8] , that is still by far the dominant clone in Israel [9] .
Carriage of KPC KP in the gastrointestinal tract is important for several reasons.
First, it may precede and possibly serve as a source for subsequent clinical infection in approximately 9% of carriers [10, 11] . Second, carriers may serve as an important reservoir for dissemination of KPC KP in healthcare facilities [12] [13] [14] . Consequently, active surveillance for carriage of KPC KP and other carbapenem-resistant Enterobacteriaceae (CRE) have become an integral part of local and national programs designed to control the spread of CRE in the healthcare setting [14] [15] [16] [17] .
Very little is known about the duration of carriage of KPC KP and of the risk factors associated with persistent carriage. We have recently published a study on a cohort of 59 known CRE carriers and found that 23 of them (38%) were positive in their subsequent hospital admission [18] . Persistent carriers were more likely to be admitted from another healthcare facility, had higher rate of recent antibiotic exposure and had a shorter duration from first detection of CRE to admission [18] . This study sampled patients at their second hospital admission and therefore did not examine the overall natural history of CRE carriage. In the current study, we followed systematically a cohort of previously known KPC KP carriers following their hospital discharge. Our aims were 1) to examine the duration of carriage of KPC KP and 2) to study the risk factors for persistent carriage.
Methods
Setting, patient selection, and collection of surveillance specimens.
The study was conducted at the Tel Aviv Sourasky Medical Center (TASMC), a 1,200-bed tertiary care hospital and at the Reut Hospital, a 300-bed long care term facility (LCTF), both in Tel Aviv, Israel. In this prospective, observational, cohort study, previously known carriers of KPC KP were identified using the computerized database of the TASMC and the National registry of KPC-KP carriers [17] . Patients were asked to enroll and provided a written informed consent. Surveillance KPC KP rectal cultures were collected as previously described [19] 
Microbiological and molecular methods.
A nylon flocked swab system with liquid Amies medium (eSwab, Copan, Brescia, Italy) was used for rectal sampling, and was immediately transferred to the laboratory Rehovot, Israel) and into a 3-ml Brain-Heart Infusion (BHI) broth tubes and were incubated overnight at 36 ºC. CRE suspicious colonies were identified and processed, including a bla KPC -PCR, as previously described [19] , with the exception that a manual biochemical kit (Enterotest™, HyLabs, Rehovot, Israel) was used for species identification. In addition, bla KPC -PCR was performed from the BHI broth [22] .
Data analysis.
Clearance of KPC KP carriage was defined as at least two consecutive negative cultures and bla KPC -PCR tests without any subsequent positive test [23] . In the REM group, the association between the baseline demographic and clinical variables and KPC KP clearance was compared using similar methods described for REC/REM groups' comparisons. Multivariate analysis was constructed with similar criteria as described above, using binary logistic regression model. The 95% C.I. for the HR of the Charlson's score was incalculable due to the low number (n=1) of the reference group. 
Results

Patients' and isolates' characteristics
Duration of KPC KP carriage following hospital discharge
Overall, 544 rectal samples were collected, of which 225 (41%) were positive.
The Out of 100 patients who had at least one negative sample, only 65 had resolution of KPC KP carriage (e.g., 2 consecutive negative tests with no subsequent positive test).
Overall, resolution of carriage was documented for 65/125 (52%). Resolution of carriage was documented in 29/75 (39%) and 36/50 (72%) of the REC and REM patients, respectively (p<0.001).
Risk factors for persistent KPC KP carriage following recent acquisition
The rates of persistent KPC KP carriage was studied in the REC group on all the variables detailed in table 1 by survival analysis. Significant risk factors at enrollment included low ADL (Barthel's) index, the presence of an invasive device, admission from a LCTF and discharge to a LTCF ( figure 4) . In all of these variables, persistence of KPC KP carriage at the end of the follow-up was found in ~50% vs. ~20% of the patients with the unfavorable vs. the favorable characteristics, respectively. ADL index correlated significantly with the place of residence and the presence of an invasive device. A multivariate analysis that included the significant variables from 
Discussion
Very little is known about the duration and the risk factors for persistent gastrointestinal carriage of KPC KP, as well as of other types of resistant gut bacteria in non-hospitalized patients. In the present study, a cohort of previously known KPC KP carriers was followed by serial rectal cultures for 3 months post hospital discharge. We found that the rate of positivity is highest (74%) when the test is done within 30 days of first KPC KP isolation, but declines to less than 30% once the time interval is over 6 months (figure 2b). Accordingly, patients with remote acquisition of KPC KP were less likely to remain positive in subsequent samplings, as was also reported by Schechner [18] and Ben-David [24] . These patients also had lower
Charlson's score, had a lower mortality rate and were more likely to be discharged to their home. The difference in the rates of persistent carriage between the two acquisition groups, is probably a reflection of the fact that patients that had survived long enough following the initial KPC KP acquisition, are healthier in general and thus less likely to be exposed to the various risk factors for persistent carriage.
Hypothetically, repeated positive KPC KP testing may result from either persistent carriage in the individual patient or from reacquisition from other patients. The later is especially of great concern in Israel, as our national policy is to cohort previously known carriers in a single ward [17] . A supporting finding for the role of reacquisition, is the association between residence at an LTCF to persistence carriage in the REC group that was also reported by Schechner et al [18] . The average prevalence of KPC KP carriage in the major LTCF's in Israel was reported to be 17% [24] , much higher than the prevalence reported in two general hospitals in Israel even at the peak of the KPC KP epidemic [13, 25] . New acquisition of KPC KP was detected in 12% of LTCF patients, and was especially common in institutions with high prevalence of KPC KP carriage or in patients that shared a room with known carrier [24] . Hence, it is likely that even following resolution of carriage in an individual patient, patients may still get re-infected in their subsequent admission, especially if they are admitted to LTCF with a high prevalence of KPC KP carriage.
Low functional status (ADL index), high comorbidity index (Charlson's score) and the presence of invasive device were identified as risk factors in the REC, the REM or in both groups, respectively. These factors were not identified as risk factors for [18] , but they were identified as risk factors for KPC KP acquisition [13, 26] . Although ADL and invasive device were correlated to residence in an LTCF in the REC group, their association to persistent KPC KP carriage is not entirely clear, as LTCF was not identified as risk factor in the REM group. Hence, it suggests that patients with poor functional status and comorbidity conditions are more likely to remain colonized by hospital-acquired organisms, such as KPC KP.
An intriguing difference between our study and previous reports [18, 24] , is the lack of association between persistent carriage and recent antibiotic therapy. This was also reported in a study that looked into the duration and risk factors for persistent carriage of ESBL-producing Enterobacteriaceae [27] . A likely explanation is the very high rate of recent antibiotic therapy in all of our patients, especially in the REC group (80%).
Accurate and reliable determination of resolution of carriage is important for both the individual patient and the medical institution, especially when a cohorting policy is implemented. Our findings indicate that a single negative test cannot serve as a reliable indication for resolution, as only 65% of patients with a negative test remained negative in subsequent testing. The total number of tests and the duration of follow-up in our study are not sufficient to determine the exact number of tests that are required for that purpose. However, our risk factor analyses can direct a better selection of patients that are less likely to remain carriers, e.g., patients admitted from home, with good functional status and with remote acquisition, in whom testing for resolution of carriage are likely to be beneficial.
An important limitation of our study is the inability to distinguish between persistence of carriage and re-infection. In theory, the use of molecular epidemiology tool might have allowed us to answer this question. However, due to the [9] ), such distinction would have been impossible in the vast majority of patients. . Also, the distinction between persistence and re-acquisition is further complicated by the fact that the KPC gene may be transmitted in-situ by the transfer of mobile genetic elements from one strain to another strain or different species altogether [28, 29] . Thus, even the isolation of a different species of KPC-producing Enterobacteriaceae, as was found in 4 patients, may not provide a definite proof for re-acquisition.
In conclusion, our study shows that although resolution of carriage occurs in the majority of patients with remote acquisition, it is uncommon in patients with recent acquisition, especially those with poor functional status who reside in an LTCF.
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